Qube Research & Technologies LTD Bio N Tech Se Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $2.11 Million - $2.65 Million	-17,254 Reduced 22.17%	60,567 $7.54 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $9.22 Million - $14.5 Million	77,821 New	77,821 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $6.6 Million - $9.97 Million	53,556 New	53,556 $7.99 Million
Q1 2022 May 09, 2022	SELL	$126.25 - $231.85 $1.81 Million - $3.33 Million	-14,349 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$216.64 - $362.52 $618,507 - $1.03 Million	-2,855 Reduced 16.59%	14,349 $3.7 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $2.61 Million - $5.67 Million	12,687 Added 280.87%	17,204 $4.7 Million
Q2 2021 Aug 13, 2021	SELL	$113.32 - $241.49 $63,459 - $135,234	-560 Reduced 11.03%	4,517 $1.01 Million
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $10.5 Million - $14.6 Million	-122,478 Reduced 96.02%	5,077 $554,000
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $3.64 Million - $6.48 Million	50,036 Added 64.55%	127,555 $10.4 Million
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $3.87 Million - $6.98 Million	67,027 Added 638.84%	77,519 $5.37 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $165,238 - $285,847	4,283 Added 68.98%	10,492 $700,000
Q1 2020 May 15, 2020	BUY	$28.55 - $92.0 $177,266 - $571,228	6,209 New	6,209 $363,000

328

40.6M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.